Roadside drug testing: unanswered questions and future challenges.

摘要

Discussions about the drug-driving issue have been gathering momentum for several years in Australia, particularly in Victoria since the Parliamentary Inquiry into the effects of drugs on road safety , and drug-driving now features as a prominent theme in both state and national road safety strategies. Since being introduced in Victoria in December 2004, random drug testing (RDT) at the roadside has been implemented or is being considered in most other states and territories. The Victorian programme originally incorporated testing for methamphetamine and cannabis [delta-9-tetra-hydrocannabinol (THC)]. The Monash University Accident Research Centre (MUARC) conducted a process evaluation of the first 6 months of the RDT programme in Victoria. Since then the programme has been expanded to include ecstasy [3,4 methylenedi-oxymethamphetamine (MDMA)] and will become more widespread as operational capabilities increase .